{
  "MSI": {
    "MLH1 silencing": "MLH1 silenced; promoter hypermethylation; MLH1-PMS2 complex disruption; repair failure; microsatellite DNA errors; high mutation rate; MMR deficiency; oncogenes alteration; tumor suppressor genes change; cancer development and progression; MSI-H tumor immunogenicity; immune system recognition and targeting.",
    "Elevated Mutation Rate": "PIK3CA; ERBB3; ERBB2; EGFR; tumor cell pleomorphism; genetic instability; mutations in oncogenes; tumor suppressor gene alterations.",
    "Increased Frequency of Somatic Mutations": "High somatic mutation frequency; MMR genes; ARID1A; RNF43; GNAS; KMT2B; PIK3CA; POLE; AXIN2; SMARCA4.",
    "Fewer Structural Genomic Alterations": "Scarce CNVs in MSI-H tumors; fewer structural genomic alterations; imbalanced gene alterations in MSS tumors; higher TP53 mutations in left-sided tumors; higher KRAS and CTNNB1 mutations in right-sided tumors.",
    "Hypermethylation of CpG islands": "CpG islands; cytosine-guanine dinucleotide repeats; hypermethylation; gene promoter silencing; gene expression; gastric cancer (GC); DNA mismatch repair system; MLH1 promoter hypermethylation.",
    "Tumor-Infiltrating Lymphocytes": "High neoantigen load; immune cell infiltration; tumor tissue response; neoantigen presentation; dMMR tumors; prominent lymphocytic response; high TIL density; immune response to neoantigens.",
    "Immune Cell Infiltration": "Significant number; lymphocytes; tumor tissue presence.",
    "Medullary Growth Pattern": "Carcinomas; colorectal; MSI-H status; high neoantigen load; poorly differentiated; syncytial growth; abundant intraepithelial lymphocytes; dMMR tumors; solid sheets of cells.",
    "Crohn's-like Lymphoid Reaction": "Dense lymphoid aggregates; tumor margin; robust immune response; neoantigens; dMMR tumors; Crohn's-like reaction.",
    "Pushing (Expansile) Margins": "Expansive growth pattern; pushing borders; high neoantigen levels; immune containment; dMMR tumors; non-infiltrative margin; microsatellite stable (MSS) tumors contrast.",
    "PD-L1 Staining": "Immunohistochemistry (IHC); PD-L1 protein expression; cell surface visualization; tumor microenvironment; PD-L1 positive cells; tumor cells; immune cells; T cells.",
    "Checkpoint Molecules": "PD-L1; PD-1 presence; infiltrating T cells; adaptive immune resistance; tumor mechanism.",
    "Pattern of Infiltration": "Vigorous immune infiltrate; variable PD-L1 positive cell distribution; invasive tumor margins; tumor nests; 'brisk' infiltration pattern; T cell band at tumor margin; 'non-brisk' infiltration pattern; scattered T cells throughout tumor.",
    "Tumor Architecture Disruption": "Infiltrating T cells; tumor architecture disruption; normal structure replacement; immune cell dominance.",
    "Varied Tumor Gland Morphology": "dMMR tumors; heterogeneous morphology; varied gland shapes; varied gland sizes; poor differentiation.",
    "Necrosis and Dirty Necrosis": "High neoantigen loads; necrosis; cytotoxic immune response; tumor necrosis; 'dirty necrosis'; debris; nuclear dust; dMMR tumors commonality.",
    "Increased Mitotic Activity": "High mitotic rates; rapid tumor cell proliferation.",
    "Mucinous/Colloid Histology": "Abundance; extracellular mucin production; MSI-H tumors.",
    "Mucinous Differentiation": "Increased mucin production; mucinous features; tumor cells; tumor stroma.",
    "Signet Ring Cell Features": "Mucin-filled cells; peripheral nucleus; indicative of MSI-H; gastric cancer.",
    "Varied Glandular Architecture": "Disorganized structure; irregular gland formation; varied gland sizes; MSI-H tumors.",
    "Well differentiation": "Less lymphatic invasion; less venous invasion; less lymph-node metastasis; compared to MSS tumors.",
    "Less Lymphatic and Venous Invasion": "MSI-H gastric cancers; less lymphatic invasion; less venous invasion; compared to MSS tumors.",
    "Lower Frequency of Lymphovascular Invasion": "Histological evidence; less frequent lymphatic invasion; less venous invasion; compared to MSS tumors.",
    "Reduced Lymph Node Metastasis": "Decreased incidence; metastasis; regional lymph nodes; relative to MSS gastric cancers.",
    "Absence of KRAS Mutations": "less common in MSI-H gastric cancer; MSI-H subtype develops through non-KRAS pathways."
  },
  "others": {
    "Genomic Instability": "Activated RAS signaling; contributes to genomic instability; induces DNA damage; interferes with chromosome segregation; exacerbates CIN phenotype.",
    "Increased Mitotic Activity": "Increased mitotic rate; atypical mitotic figures; abnormal mitoses; high cellular proliferation.",
    "High Mitotic Index": "High number of mitotic cells; atypical mitoses; irregular mitotic figures; rapid tumor growth; increased metastasis likelihood.",
    "Nuclear Pleomorphism": "Variation in nuclear size and shape; nuclei size disparity; irregular nuclear shapes; oval to highly irregular forms.",
    "Hyperchromasia": "Nuclei appear darker; excess DNA content.",
    "Irregular Nuclear Contours": "Uneven nuclear borders; indented nuclear contours.",
    "Prominent Nucleoli": "Prominent nucleoli; increased number of nucleoli; sign of heightened protein synthesis; rapid cell division indicator.",
    "Chromatin Clumping": "Irregular chromatin clumping; patchy nuclear appearance.",
    "Multipolar spindles": "Multipolar spindles; asymmetric nuclear division; uneven genetic material distribution; cells with abnormal nuclear shapes and sizes.",
    "Tumor Heterogeneity": "CIN-induced genetic heterogeneity; RAS-driven proliferation of diverse cells; increased tumor complexity; potential influence on drug resistance; enhancement of metastatic potential.",
    "Increased TP53 Mutations": "TP53 enrichment in high-CIN tumors; link to mitotic stress; TP53 malfunctions; increased mitotic figures in histology; atypical nuclear features; increased nuclear size; irregular nuclear contours; hyperchromasia; prominent nucleoli; genomic instability; altered cell cycle regulation; variety of cell types; abnormal tumor structures.",
    "Cell Proliferation": "RAS pathway activation; promotes cell division; genomic instability in CIN; proliferation of abnormal cells; contributes to tumor growth; aids tumor progression.",
    "Poorly Differentiated Tumor Cells": "High-grade dedifferentiation; higher likelihood of metastasis.",
    "Lymphovascular Invasion": "Tumor cells in lymphatic vessels; tumor cells in blood vessels; direct indication of metastasis.",
    "Perineural Invasion": "Tumor cells invading perineural space; association with aggressive tumors; increased risk of metastasis.",
    "Tumor Budding": "Small clusters of cancer cells at invasive front; individual cells at invasive front; sign of aggressive tumor phenotype; correlated with metastasis.",
    "Desmoplasia": "Pronounced desmoplastic reaction; growth of fibrous tissue; connective tissue increase; association with aggressive tumors.",
    "Depth of Invasion": "Deeper gastric wall invasion; invasion into subserosal layer; invasion beyond subserosa; higher metastasis risk.",
    "Correlated Lauren's Intestinal Type": "Well-formed glandular structures; intestinal epithelium resemblance; chronic gastritis initiation; progression to atrophy; intestinal metaplasia; dysplasia; carcinoma development; common in high-incidence regions; environmental factor association; diet-related; Helicobacter pylori infection.",
    "Increased PIK3CA mutations": "PIK3CA enrichment in low-CIN tumors; increased cell growth and proliferation; high mitotic index; dense cellular arrangement; increased microvessel density in tumor stroma; variable cellular morphology and architecture; fewer apoptotic cells than expected; contributes to tumor cell invasion; aids in metastasis.",
    "Reduced or Aberrant Staining for E-cadherin": "Immunohistochemistry (IHC) for E-cadherin; reduced staining; absent staining; areas with CDH1 mutations; loss of protein expression.",
    "Signet Ring Cells": "Loss of E-cadherin function; CDH1 mutations; presence of signet ring cells; large vacuole in cells; nucleus at periphery; signet ring-like appearance; indicative of poor prognosis.",
    "Loss of Cell Cohesion": "Mutations in CDH1; loss of E-cadherin function; reduced intercellular adhesion; diffuse infiltration of gastric wall; isolated tumor cells; small clusters of cells; lack of glandular structures; characteristic of diffuse-type gastric cancer; Lauren's classification.",
    "Altered Cell Adhesion": "Claudin-18 role in cell-cell adhesion; alterations affect epithelial integrity; observed gaps between cells; loss of 'honeycomb' pattern in gastric epithelium.",
    "Abnormal Cell Shapes and Arrangement": "RHO gene mutations; changes in cell morphology; altered actin cytoskeleton; elongated cells; spindle-shaped cells; epithelial-to-mesenchymal transition (EMT) indication; observed in GS subtype of GC.",
    "Dysregulated Actin Cytoskeleton": "RHO gene mutations; actin cytoskeleton alterations; affects cell shape and motility; not observable in H&E staining; irregular tumor cell arrangement; visualized with cytoskeletal markers; IHC; fluorescent stains."
  }
}